Description
VALBHS TOTAL PARENTERAL NUTRITION AND COMPOUNDING
First action · last action
2022-10-24 · 2023-11-24
Transactions
2
First transaction's obligation
$167,412
Base + all options value (sum of deltas)
$163,666
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-10-24+$167,412= $167,412
- Mod P000012023-11-24-$3,746= $163,666
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-10-24 | +$167,412 | $167,412 | VALBHS TOTAL PARENTERAL NUTRITION AND COMPOUNDING |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-11-24 | −$3,746 | $163,666 | VALBHS TOTAL PARENTERAL NUTRITION AND COMPOUNDING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NDPWXJSVYVH9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0733 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q517 · PHARMACY SERVICES | $89,282 | FY2026 |
| 36C26226N0872 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $164,265 | FY2026 |
| 36C26226N0870 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $167,369 | FY2026 |
| 36C26226N0873 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $140,823 | FY2026 |
| 36C26226N0871 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $231,746 | FY2026 |
| 36C24826P0477 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $26,837 | FY2026 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226P1412 | ASD SPECIALTY HEALTHCARE, LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $38,220 | FY2026 |
| 36C26226N0818 | GALDERMA LABORATORIES, L.P. | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $50,880 | FY2026 |
| 36C26226F0313 | PROGENICS PHARMACEUTICALS INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $180,436 | FY2026 |
| 36C26226F0314 | NOVARTIS PHARMACEUTICALS CORPORATION | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $823,062 | FY2026 |
| 36C26226N0782 | CYCLOMEDICA USA, LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $40,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26223P0056_3600_-NONE-_-NONE- · retrieved 2026-09-26.